The Evidence Speaks (May 2020)
This edition includes: substance use changes with opioid agonist therapy; palliative care in the ICU; and priorities of patients with glomerular disease
Read MoreThis edition includes: substance use changes with opioid agonist therapy; palliative care in the ICU; and priorities of patients with glomerular disease
Read MoreAs we enter into another exciting year of improving health outcomes for BC and beyond, we're reflecting on some of the CHÉOS research from the past year.
Read MoreDrs. Rick Sawatzky and Jose Valderas were awarded a 2019 UBC Partnership Development Fund Grant for a collaborative initiative between CHÉOS and the University of Exeter, UK.
Read MoreRenewed as a Canada Research Chair in Patient-Centered Outcomes, Dr. Rick Sawatzky looks to change the way some data are collected and interpreted.
Read MoreThe conference features presentations and seminars from researchers from around the world, including CHÉOS Scientists.
Read MoreRick Sawatzky and Aggie Black were honoured at a gala ceremony on November 17.
Read More